It would be of considerable interest to next test the various Rac1 inhibitors, first in cell-based systems and then in animal models of bladder cancer, to sort out which specific inhibitors are effective in curtailing bladder cancer growth and progression. This evidence concerns the gene RAC1 and urinary bladder carcinoma.